Diana DeGette (D-CO)

INSULIN Act of 2026

H.R. 10227 · House bill Health

A Democratic bill with 3 Republican cosponsors · See all 19 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, titled the INSULIN Act of 2026, aims to reduce the cost of insulin and provide patient protections. For plan years beginning on or after January 1, 2028, group health plans and health insurance issuers must cover selected insulin products without applying a deductible. These plans cannot impose cost-sharing requirements for a 30-day supply that exceed thirty-five dollars or twenty-five percent of the negotiated price. The bill also establishes a study on uninsured individuals who use insulin, creates a resource center and hotline, and works to expedite biosimilar competition. Furthermore, the Secretary of Health and Human Services, the Secretary of Labor, and the Secretary of the Treasury are given implementation authorities.

Yes· 3 of 34

  • Scored +9

    Would households on low incomes be better off under this?

    Significantly reduces the cost of life-saving medicine and provides assistance for the uninsured.

  • Scored +9

    Does this lower the price of prescription medicines?

    Directly caps insulin costs at $35 or 25% of the negotiated price.

  • Scored +8

    Would people with disabilities be better off under this?

    Directly benefits people with the chronic disability of diabetes.

The opposite

  • Scored -2

    Would business owners be better off under this?

    May increase costs for employers providing group health plans.

  • Scored -2

    Does this lower what people pay for private health insurance?

    Capping cost-sharing may lead insurers to raise premiums to recover costs.